908 Devices Inc.
MASSHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeHeadquartered within the healthcare sector, 908 Devices Inc. focuses on Medical Devices services and products. 908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. With a market capitalization of $474.9M, it sits in small-cap territory. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample.
Market Cap
$474.9M
Beta
0.63
P/E (TTM)
—
P/E (Fwd)
-37.37
EPS (TTM)
$-0.94
EPS (Fwd)
$-0.31
ROE
-24.9%
ROA
-6.8%
Cash
$101.5M
Total Debt
$4.3M
Free CF
$18.7M
52W Change
37.9%
Annual Financials
Cash vs Debt
Where MASS stands vs its 150-day and 200-day moving averages
As of the October 13, 2026 close, MASS finished 39.39% above its 150-day moving average ($8.48) and 49.43% above its 200-day moving average ($7.91). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MASS overbought or oversold?
At the October 13, 2026 close, MASS's RSI(14) was 57.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $101.5M in cash comfortably exceeding the $4.3M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $18.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -24.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been uneven over recent years, ranging from $46.9M to $56.2M.
The relatively low beta of 0.62 suggests MASS is a less volatile holding compared to the broader index. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for 908 Devices Inc. and its sector.